Home › Endometrial Cancer › Illinois › Danville
Endometrial Cancer clinical trials in Danville, IL
4 studies for Endometrial Cancer are looking for participants at sites in and around Danville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Carle at The Riverfront, Danville
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
RecruitingPhase 3
- Carle at The Riverfront, Danville
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Carle at The Riverfront, Danville
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RecruitingPhase 2
- Carle at The Riverfront, Danville
Endometrial Cancer trials in other cities
- Houston, TX69 studies
- New York City, NY53 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN37 studies
- Los Angeles, CA35 studies
- St. Louis, MO29 studies
- Philadelphia, PA29 studies
- San Antonio, TX27 studies
- Columbus, OH26 studies
- Chicago, IL26 studies
- Queens, NY26 studies
Other studies in Danville
- Lung Cancer9 studies
- Non-Small Cell Lung Cancer8 studies
- Prostate Cancer7 studies
- Colorectal Cancer6 studies
- Breast Cancer5 studies
- Melanoma5 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Laryngeal Cancer5 studies
- Oral Cancer5 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
- Pancreatic Cancer4 studies
- Hypopharyngeal Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.